RxDoctor Payments Data

Eileen Flynn Richards

Adult Health · Centereach, NYNPI 1780671446

Payments from drug & device makers

$3,620in general payments, 2019–2025

Across 94 payments — averaging $38.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$836
  • Otsuka America Pharmaceutical, Inc.$662
  • Alkermes, Inc.$615
  • AbbVie$366
  • E.r. Squibb & Sons, L.L.C.$150
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$145
  • plus $846 from 14 others

What the payments were for

  • Food & beverage$3,54698%
  • Education$742%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,620 in reported general payments places this provider in the 85th percentile of 3,828 adult health providers in New York.

See all adult health providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole78$132,913
IngrezzaValbenazine Tosylate16$105,313
FanaptIloperidone56$73,677
NuedextaDextromethorphan Hbr/Quinidine49$68,043
Aripiprazole672$17,416
Divalproex Sodium ErDivalproex Sodium227$14,583
Lurasidone Hcl43$8,897
Divalproex Sodium189$7,903
Rivastigmine51$7,769
Olanzapine324$7,720
Quetiapine Fumarate592$7,431
Fluvoxamine Maleate ErFluvoxamine Maleate24$7,218
Risperidone683$7,012
Aripiprazole OdtAripiprazole13$6,696
Quetiapine Fumarate ErQuetiapine Fumarate97$5,925

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$662$132,91378 claims
Neurocrine Biosciences, Inc.Ingrezza$836$105,31316 claims
Vanda Pharmaceuticals Inc.Fanapt$102$73,67756 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$27$5,39312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,828 adult health providers in New York.

Other adult health in Centereach

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →